Galera Therapeutics, Inc. (GRTX) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-05-29

Galera Therapeutics, Inc. (GRTX) has filed 1 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-05-29. 5 Form 8-K material event filings were reported by GRTX in the last 90 days. InsiderAlpha tracks every GRTX SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Galera Therapeutics, Inc. (GRTX)

SEC CIK	0001563577

90-Day SEC Filing Activity

Form 4 filings (90d)	1
Form 8-K filings (90d)	5
Latest Form 4 filing	2026-05-29

Recent GRTX Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-05-15	Emerald Bioventures, LLC	10% Owner	J — Other acquisition / disposition	20.81M	—	—	SEC
2026-04-07	FRIEDMAN MICHAEL R.	Insider	J — Other acquisition / disposition	5.34M	—	—	SEC
2026-04-07	CHANG NANCY T	Insider	J — Other acquisition / disposition	1.18M	—	—	SEC

All transactions sourced from SEC EDGAR Form 4 filings for Galera Therapeutics, Inc. (GRTX). Updated in real time as new filings are submitted to the SEC.

Most-Active GRTX Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
Emerald Bioventures, LLC	2	—

Recent GRTX Form 8-K Material Events

2026-07-13 — Item 3.03, 5.03, 9.01 [SEC]
2026-07-07 — Item 8.01 [SEC]
2026-05-19 — Item 8.01 [SEC]
2026-05-15 — Item 5.03, 9.01 [SEC]
2026-05-11 — Item 5.07 [SEC]

Recent Insider Filings

2026-05-29 — Emerald Bioventures, LLC (10% Owner)
2026-04-09 — FRIEDMAN MICHAEL R. (Insider)
2026-04-09 — CHANG NANCY T (Insider)
2025-11-24 — Sorensen Mel (President and CEO)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in GRTX insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

GRTX Insider Trading — FAQ

What is the latest insider trade for GRTX?: Galera Therapeutics, Inc. (GRTX) had 1 insider filings in the last 90 days, with the most recent on 2026-05-29. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying GRTX stock?: 0 insider purchases of GRTX were filed in the last 90 days.
How many insiders are selling GRTX stock?: 0 insider sales of GRTX were filed in the last 90 days.
Where can I see GRTX SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every GRTX SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live GRTX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.